EPRX · Eupraxia Pharmaceuticals Inc. · Documents
Market Cap
$501.50M
Shares
66.07M
Volume · Oct 20
938.7K
Avg daily vol (3M)
635K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2025-03-21 | 2025-03-20 | |
| 40-F | — | 2025-03-20 | 2024-12-31 | |
| 6-K | — | 2025-02-25 | — | |
| 6-K | — | 2025-02-18 | — | |
| 6-K | — | 2024-11-20 | — | |
| 6-K | — | 2024-11-14 | — | |
| 6-K | — | 2024-11-13 | 2024-11-12 | |
| 6-K | — | 2024-11-13 | — | |
| 6-K | — | 2024-11-07 | — | |
| 6-K | — | 2024-11-01 | 2024-10-31 | |
| 6-K | — | 2024-10-28 | — | |
| 6-K | — | 2024-10-15 | — | |
| 6-K | — | 2024-10-10 | — | |
| 6-K | — | 2024-10-02 | — | |
| 6-K | — | 2024-09-19 | — | |
| 6-K | — | 2024-09-11 | — | |
| 6-K | — | 2024-09-04 | — | |
| 6-K | — | 2024-08-07 | — | |
| 6-K | — | 2024-08-02 | — | |
| 6-K | — | 2024-07-08 | — | |
| 6-K | — | 2024-07-03 | — | |
| 6-K | — | 2024-06-06 | — | |
| 6-K | — | 2024-06-05 | — | |
| 6-K | — | 2024-05-23 | — | |
| 6-K | — | 2024-05-22 | — | |
| 6-K | — | 2024-05-21 | — | |
| 6-K | — | 2024-05-15 | — | |
| 6-K | — | 2024-05-14 | — | |
| 6-K | — | 2024-05-08 | — | |
| 6-K | — | 2024-05-02 | — | |
| 6-K | — | 2024-04-11 | — | |
| 6-K | — | 2024-04-10 | — | |
| 6-K | — | 2024-04-08 | — | |
| 6-K | — | 2024-04-08 | — | |
| 6-K | — | 2024-04-05 | — | |
| 6-K | — | 2024-04-03 | — | |
| 6-K | — | 2024-04-01 | — | |
| 40-F | — | 2024-04-01 | 2023-12-31 | |
| 6-K | — | 2024-03-18 | — | |
| 6-K | — | 2024-03-15 | — | |
| 6-K | — | 2024-03-12 | — | |
| 6-K | — | 2024-03-11 | — |
Showing 51–92 of 92 filings